Literature DB >> 16903225

Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades?

P Dény1.   

Abstract

Hepatitis D virus (HDV) is a satellite of hepatitis B virus (HBV) for transmission and propagation, and infects nearly 20 million people worldwide. The HDV genome is composed of a compact circular single-stranded negative RNA genome with extensive intramolecular complementarity. Along with epidemiological, geographic distribution and pathological patterns, the variability of HDV has been limited to three genotypes and two subtypes that have been characterized to date. Recently, extensive phylogenetic reconstructions based on the delta antigen gene and full-length genome sequence data, have shown a wide and probably ancient radiation of African lineages, suggesting that the genetic variability of HDV is much more complex than previously thought. Indeed, sequences previously affiliated with genotype IIb should now be considered as belonging to clade 4 (HDV-4) and African HDV sequences segregate within four additional clades: HDV-5, HDV-6, HDV-7 and HDV-8. These results bring the geographic distribution of HDV closer to the genetic variability of its helper HBV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16903225     DOI: 10.1007/3-540-29802-9_8

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  46 in total

1.  Current concept in the pathophysiology of hepatitis delta infection.

Authors:  Grazia Anna Niro; Antonina Smedile
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

Review 2.  Host RNA circles and the origin of hepatitis delta virus.

Authors:  John M Taylor
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

3.  Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.

Authors:  Benjamin Y Winer; Elham Shirvani-Dastgerdi; Yaron Bram; Julie Sellau; Benjamin E Low; Heath Johnson; Tiffany Huang; Gabriela Hrebikova; Brigitte Heller; Yael Sharon; Katja Giersch; Sherif Gerges; Kathleen Seneca; Mihai-Alexandru Pais; Angela S Frankel; Luis Chiriboga; John Cullen; Ronald G Nahass; Marc Lutgehetmann; Jared E Toettcher; Michael V Wiles; Robert E Schwartz; Alexander Ploss
Journal:  Sci Transl Med       Date:  2018-06-27       Impact factor: 17.956

Review 4.  Hepatitis D virus coinfection and superinfection.

Authors:  Francesco Negro
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

5.  Standardized one-step real-time reverse transcription-PCR assay for universal detection and quantification of hepatitis delta virus from clinical samples in the presence of a heterologous internal-control RNA.

Authors:  Caroline Scholtes; Vinca Icard; Majid Amiri; Philippe Chevallier-Queyron; Mary-Anne Trabaud; Christophe Ramière; Fabien Zoulim; Patrice André; Paul Dény
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

6.  Protein-peptide arrays for detection of specific anti-hepatitis D virus (HDV) genotype 1, 6, and 8 antibodies among HDV-infected patients by surface plasmon resonance imaging.

Authors:  Marie-Bernadette Villiers; Jean-Claude Cortay; Sandra Cortès; Bénédicte Bloquel; Ségolène Brichler; Carine Brakha; Alan Kay; Nisrine Falah; Fabien Zoulim; Christophe Marquette; Patrice N Marche; Paul Dény
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

Review 7.  Control of ADAR1 editing of hepatitis delta virus RNAs.

Authors:  John L Casey
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

8.  Hepatitis D Virus: A Call to Screening.

Authors:  Joseph Ahn; Robert G Gish
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-10

Review 9.  Origin of hepatitis delta virus.

Authors:  John Taylor; Martin Pelchat
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

10.  The C-terminal sequence of the large hepatitis delta antigen is variable but retains the ability to bind clathrin.

Authors:  Yu-Cheng Wang; Chi-Ruei Huang; Mei Chao; Szecheng J Lo
Journal:  Virol J       Date:  2009-03-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.